サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：核酸検査キット市場2022-2028
市場調査レポート
商品コード
1215771

核酸検査キット市場2022-2028

Nucleic Acid Testing Kits Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
核酸検査キット市場2022-2028
出版日: 2023年01月20日
発行: Orion Market Research
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

核酸検査キットの世界市場は、予測期間中に7.9%の大幅なCAGRで成長すると予測されています。核酸検査キットの世界市場の開拓は、世界各地でのCOVID-19の急増、技術的に高度な診断手段に対する高い需要とともに、新規バイオテクノロジー診断技術開発のための政府機関および民間機関による投資の増加によって推進されています。これとは別に、遺伝子関連疾患、がん性疾患、細菌やウイルスによる感染症などの治療に核酸検査が多く採用されていることから、予測期間中にその需要に拍車がかかると予想されます。

核酸検査キットの世界市場は、疾患検出とエンドユーザーに基づいて区分されます。疾患検出に基づいて、市場はコロナウイルス、がん、肝炎、およびその他に細分化されます。同様に、エンドユーザーに基づいて、市場は病院や診療所、学術・研究機関に細分化されます。

地域的には、核酸検査キット市場は、北米、欧州、アジア太平洋地域、その他の地域に区分されます。欧州は、予測期間中に顕著な市場成長を示すと予想されます。英国は、市場に大きなシェアを貢献している主要経済国です。COVID-19陽性例の急激な増加により、COVID-19感染を検出するための迅速診断検査キットの需要が高まりました。ワールドメーターによると、2021年5月8日現在、英国で報告されたCOVID-19の総症例数は440万件でした。2021年5月6日現在、英国で実施された検査（処理または送付）は、4つの柱すべてで1億5,800万件にのぼります。同国におけるCOVID-19診断検査件数の増加は、市場の成長を後押ししました。

目次

第1章 レポート概要

  • 現在の産業分析と成長性の展望
  • COVID-19が世界の核酸検査キット産業に与える影響
  • 世界の核酸検査キット産業の回復シナリオ
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場の概要とインサイト

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • レコメンデーション
    • まとめ

第3章 競合情勢

  • 主要企業の分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 核酸検査キットの世界市場：疾患検出別
    • コロナウイルス
    • がん
    • 肝炎
    • その他
  • 核酸検査キットの世界市場：エンドユーザー別
    • 病院・診療所
    • 学術・研究機関

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東＆アフリカ

第6章 企業プロファイル

  • Abbott Laboratories
  • Agilent Technology, Inc.
  • BGI Group
  • Biomedomics Inc.
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • F.Hoffmann-La Roche AG
  • Henry Schein Inc.
  • Illumina, Inc.
  • Innovita Biological Technology Co. Ltd.
  • Mayo Clinic Laboratories
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • Qiagen N.V.
  • Robert Bosch GmbH
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Danaher Corp.
  • Epitope Diagnostics, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 2. GLOBAL NUCLEIC ACID TESTING KITS FOR CORONAVIRUS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL NUCLEIC ACID TESTING KITS FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL NUCLEIC ACID TESTING KITS FOR HEPATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL NUCLEIC ACID TESTING KITS FOR OTHER DISEASE DETECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 7. GLOBAL NUCLEIC ACID TESTING KITS FOR HOSPITAL AND CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL NUCLEIC ACID TESTING KITS FOR ACADEMICS AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. NORTH AMERICAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 13. EUROPEAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 14. EUROPEAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 15. EUROPEAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 16. ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 19. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

 

LIST OF FIGURES

  • 1. GLOBAL NUCLEIC ACID TESTING KITS MARKET SHARE BY DISEASE DETECTION, 2021 VS 2028 (%)
  • 2. GLOBAL NUCLEIC ACID TESTING KITS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 3. GLOBAL NUCLEIC ACID TESTING KITS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL NUCLEIC ACID TESTING KITS FOR CORONAVIRUS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL NUCLEIC ACID TESTING KITS FOR CANCER MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL NUCLEIC ACID TESTING KITS FOR HEPATITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL NUCLEIC ACID TESTING KITS FOR OTHER DISEASE DETECTION MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL NUCLEIC ACID TESTING KITS FOR HOSPITAL AND CLINIC MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL NUCLEIC ACID TESTING KITS FOR ACADEMICS AND RESEARCH INSTITUTES MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 10. US NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 11. CANADA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. UK NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. FRANCE NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. GERMANY NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. ITALY NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. SPAIN NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. REST OF EUROPE NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. INDIA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. CHINA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. JAPAN NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SOUTH KOREA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026827

Title:Global Nucleic Acid Testing Kits Market Size, Share, and Trends Analysis Report, by Disease detection (Coronavirus, Cancer, Hepatitis, and Others), By End-User (Hospital and Clinic, and Academics and Research Institutes), Forecast Periods (2022-2028).

The global nucleic acid testing kits market is anticipated to grow at a substantial CAGR of 7.9% during the forecast period. The global nucleic acid testing kits market growth is being driven by the surging prevalence of COVID-19 in various parts of the globe, and rising investment by government and private agencies for novel biotechnological diagnostic techniques development along with high demand for technologically advanced diagnostic measures. Apart from these, the high adoption of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by bacteria or viruses is anticipated to spur their demand during the forecast period.

The global nucleic acid testing kits market is segmented based on disease detection and end-user. Based on disease detection, the market is sub-segmented into coronavirus, cancer, hepatitis, and others. Similarly, based on end-user, the market is sub-segmented into hospitals and clinics, and academics and research institutes.

Geographically, the nucleic acid testing kits market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Europe is expected to show notable growth in the market during the forecast period. The UK is the major economy contributing a significant share to the market. The exponential growth in positive COVID-19 cases gave rise to the demand for quick diagnostic test kits to detect the COVID-19 infection. As per the Worldometer, as of 8th May 2021, the total number of COVID-19 cases reported in the UK was 4.4 million. As of 6th May 2021, there have been 158 million tests (either processed or sent out) conducted across all 4 pillars in the UK. The hike in the number of COVID-19 diagnostic tests in the country boosted the market growth.

The major market players in the global nucleic acid testing kits market include Agilent Technology Inc., Abbott Laboratories, BGI Group, F.Hoffmann-La Roche, PerkinElmer, Inc., and Thermo Fisher Scientific, among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, PerkinElmer, Inc., announced that the USFDA has approved its new coronavirus nucleic acid detection kit for an additional indication that permits the use of saliva as a specimen type. Moreover, in June 2021, Natera, Inc., and BGI Genomics Co., Ltd., (BGI Group) launched the BGI/Natera Signatera Assay. The product has been utilized in numerous clinical studies across non-small cell lung, bladder, breast, and colorectal cancers, to identify molecular residual disease (MRD). Similarly, in May 2020, Beckman Coulter Life Sciences launched RNAdvance Viral XP, a new RNA extraction kit validated for use in infectious disease and real-time PCR virus research.

Research Methodology

The market study of the global nucleic acid testing kits is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Nucleic acid testing kits Research and Analysis by Disease Detection
  • Global Nucleic acid testing kits Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global nucleic acid testing kits market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global nucleic acid testing kits market.
  • Insights about market determinants that are stimulating the global nucleic acid testing kits market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Nucleic Acid Testing Kits Industry
  • Recovery Scenario of Global Nucleic Acid Testing Kits Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nucleic Acid Testing Kits Market by Disease detection
    • 4.1.1. Coronavirus
    • 4.1.2. Cancer
    • 4.1.3. Hepatitis
    • 4.1.4. Other
  • 4.2. Global Nucleic Acid Testing Kits Market by End-User
    • 4.2.1. Hospital and Clinics
    • 4.2.2. Academics and Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Agilent Technology, Inc.
  • 6.3. BGI Group
  • 6.4. Biomedomics Inc.
  • 6.5. BioMerieux S.A.
  • 6.6. Bio-Rad Laboratories, Inc.
  • 6.7. Danaher Corp.
  • 6.8. F.Hoffmann-La Roche AG
  • 6.9. Henry Schein Inc.
  • 6.10. Illumina, Inc.
  • 6.11. Innovita Biological Technology Co. Ltd.
  • 6.12. Mayo Clinic Laboratories
  • 6.13. Merck KGaA
  • 6.14. Mylab Discovery Solutions Pvt. Ltd.
  • 6.15. Qiagen N.V.
  • 6.16. Robert Bosch GmbH
  • 6.17. Siemens AG
  • 6.18. Thermo Fisher Scientific, Inc.
  • 6.19. Danaher Corp.
  • 6.20. Epitope Diagnostics, Inc.